Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MB Sugars is a specialized manufacturer of high-purity sugar and carbohydrate-based excipients for the global pharmaceutical and nutraceutical industries. Headquartered in India, the company produces a wide range of pharma-grade ingredients including sucrose, mannitol, sorbitol, and specialty sugars like trehalose and galactose. These products are essential for drug stabilization, taste-masking, and as bulking agents in various dosage forms such as tablets, syrups, and injectables. MB Sugars operates state-of-the-art manufacturing facilities that comply with international quality standards like GMP and ISO. The company serves as a critical supplier to major pharmaceutical firms worldwide, ensuring high-quality raw materials for complex drug formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MB Sugars.